Zeil Rosenberg, MD, MPH. is a vaccine, infectious disease control and medical device expert who has led multi-disciplinary global teams to develop novel vaccine delivery technologies and immunotherapy products for infectious diseases and malnutrition. Dr Rosenberg drove the worldwide commercial scale–up of specialized vaccine injection devices needed to prevent HIV/AIDS transmission during global mass immunization initiatives and, working with UNICEF experts, championed a successful private-public partnership to eliminate maternal and neonatal tetanus by safely immunizing 90 million women worldwide. Trained at Stanford, UCSF and Columbia Dr. Rosenberg is a Specialty Fellow of the American Academy of Pediatrics and the New York Academy of Medicine. As an adjunct faculty member at Columbia’s Mailman School of Public Health he advises start-up companies with high-impact public health potential.
Areas of Expertise